CVKD

Cadrenal Therapeutics Inc Cross-source read$1.09 7.63%
Health CareCUSIP 127636207· EOD Sep 11, 2026

Among active 13F managers last quarter, 1 added and 1 reduced; the largest holder to move was Clearstead Advisors, LLC (added). Over the last 180 days, 1 insider sold and none bought, a net -$388K in open-market trades.

Tracked 13F holders
16
8 in Q2 2026 filings
13F value (tracked)
$303K
Smart-money readMixed
Net sellingNet buying
Funds · active managers, latest 13F
1 adding · 1 trimming
Insiders · Form 4 open-market, 180d
0 buying · 1 selling · -$388K
US House · STOCK Act, 180d
0 buying · 0 selling

The legs disagree, or only one of them leans.

Price & smart-money activity

$1.09 7.63%4Y -98.2%
$1.00$17.42$33.83$50.24$66.662023202420252026272224182322
Hover for who · click for detailEnd-of-day closing prices52w $1.09 – $14.20

Who owns CVKD?

16 tracked 13F filers · ranked by shares held

16 tracked 13F filers disclose a position in CVKD as of the latest SEC 13F filings, a combined $303K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Vanguard Capital Management LLC50K
$167K
+11%
Added · +5K sh
Q2 2026
2Geode Capital Management, LLC19K
$64K
−12%
Reduced · −3K sh
Q2 2026
3Vanguard Fiduciary Trust Co8K
$28K
Held
Q2 2026
4JPMorgan Chase & Co8K
$32K
Held
Q1 2026
5Grove Bank & Trust1K
$3K
New
+1K sh
Q2 2026
6Clearstead Advisors, LLC650
$2K
Added
Added · +650 sh
Q2 2026
7Tower Research Capital LLC (TRC)393
$2K
−26%
Reduced · −139 sh
Q1 2026
8Quest 10 Wealth Builders, Inc.380
$1K
New
+380 sh
Q2 2026
9Osaic Holdings, Inc.300
$2K
−40%
Reduced · −200 sh
Q1 2026
10Rockefeller Capital Management L.P.150
$768
−50%
Reduced · −150 sh
Q1 2026
11Morgan Stanley100
$512
−91%
Reduced · −980 sh
Q1 2026
12Wells Fargo & Company99
$507
Held
Q1 2026
13Archer Investment Corp35
$117
Held
Q2 2026
14IFP Advisors, Inc30
$100
Held
Q2 2026
15UBS Group AG3
$15
−100%
Reduced · −1K sh
Q1 2026
16Citigroup Inc1
$5
New
+1 sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is CVKD being bought or sold by institutions?

Last quarter, 1 fund added to an existing position in CVKD, while 1 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Added
1
added to an existing position
Reduced
1
reduced, still holding
Biggest moves · ranked by size of the change, positions above a floor

Funds that own CVKD also own

CompanyCo-held byTheir position there
Vanguard S&P 500 ETFVOO4 funds$1.0B
Apple IncAAPL4 funds$559.0M
Microsoft CorpMSFT4 funds$381.1M
Nvidia CorpNVDA4 funds$332.7M
Paccar IncPCAR4 funds$296.0M
Invesco QQQ Trust Series 1QQQ4 funds$278.1M
Amazon.com IncAMZN4 funds$264.9M
Ishares Russell 1000 GrowthIWF4 funds$251.8M
SS SPDR S&P 500 ETF Trust-USSPY4 funds$247.2M
Alphabet Inc-CL AGOOGL4 funds$243.0M
Ste STR SPDR PT DW EU ETFSPDW4 funds$197.7M
Vanguard Value ETFVTV4 funds$179.8M

Ranked by how many of CVKD's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in CVKD.

Insider activity (Form 4)

Full insider page →
Sells · 180d
$388K
1 insider
Net · 180d
-$388K
22 open-market transactions
DateInsiderRoleActionSharesValue
Jun 29, 2026Pham Quang XChairman and CEO, Director, 10% OwnerSell (S)7K$22K
Jun 26, 2026Pham Quang XChairman, CEO and Interim CFO, Director, 10% OwnerSell (S)9K$28K
Jun 25, 2026Pham Quang XChairman, CEO and Interim CFO, Director, 10% OwnerSell (S)2K$6K
Jun 23, 2026Pham Quang XChairman, CEO and Interim CFO, Director, 10% OwnerSell (S)2K$7K
Jun 22, 2026Pham Quang XChairman, CEO and Interim CFO, Director, 10% OwnerSell (S)9K$33K
Jun 17, 2026Pham Quang XChairman, CEO and Interim CFO, Director, 10% OwnerSell (S)513$2K
Jun 16, 2026Pham Quang XChairman, CEO and Interim CFO, Director, 10% OwnerSell (S)4K$11K
Jun 15, 2026Pham Quang XChairman, CEO and Interim CFO, Director, 10% OwnerSell (S)4K$13K
Jun 12, 2026Pham Quang XChairman, CEO and Interim CFO, Director, 10% OwnerSell (S)13K$51K
Jun 11, 2026Pham Quang XChairman, CEO and Interim CFO, Director, 10% OwnerSell (S)1K$6K
Jun 10, 2026Pham Quang XChairman, CEO and Interim CFO, Director, 10% OwnerSell (S)4K$15K
Jun 9, 2026Pham Quang XChairman, CEO and Interim CFO, Director, 10% OwnerSell (S)13K$53K

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
26
Insiders
Form 4 open-market
01-$388K
US House
STOCK Act trades
00$0
Sector rotation
CVKD is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

8 tracked filers in Q2 2026 filingsstill filing
0918Q3 2024Q1 2025Q3 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $266K
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Share classes

Class13F holdersValue held
CVKDthis pagecs16 funds$303K
127636108Stock3 funds$652

Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.

Recent filings

15 most recent

Keep exploring

Connected entities for CVKD

Browse more

Build

Ask your agent what changed in CVKD

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/CVKD/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for CVKD.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for CVKD. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.